In this study, we demonstrated that CalebinA is effective even in gemcitabine-resistant pancreatic cancer cells, inhibiting tumor growth, angiogenesis, and invasion through suppression of NF-κB activity. The gene discussed is NFKB1; the disease is pancreatic neoplasm.